» Articles » PMID: 10753864

SOX9 Enhances Aggrecan Gene Promoter/enhancer Activity and is Up-regulated by Retinoic Acid in a Cartilage-derived Cell Line, TC6

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Feb 7
PMID 10753864
Citations 189
Authors
Affiliations
Soon will be listed here.
Abstract

SOX9 is a transcription factor that plays a key role in chondrogenesis. Aggrecan is one of the major structural components in cartilage; however, the molecular mechanism of aggrecan gene regulation has not yet been fully elucidated. TC6 is a clonal chondrocytic cell line derived from articular cartilage. The purpose of this study was to examine whether SOX9 modulates aggrecan gene expression and to further identify molecules that regulate Sox9 expression in TC6 cells. SOX9 overexpression in TC6 cells enhanced by approximately 3-fold the transcriptional activity of the AgCAT-8 construct containing 8-kilobase (kb) promoter/first exon/first intron fragments of the aggrecan gene. SOX9 enhancement of aggrecan promoter activity was lost when we deleted a 4.5-kb fragment from the 3'-end of the 8-kb fragment corresponding to the region including the first intron. In TC6 cells, SOX9 enhanced the transcriptional activity of a reporter construct containing the Sry/Sox consensus sequence >10-fold. SOX9 enhancement of aggrecan gene promoter activity and SOX9 transactivation through the Sry/Sox consensus sequence were not observed in osteoblastic osteosarcoma cells (ROS17/2.8), indicating the dependence on the cellular background. Northern blot analysis indicated that TC6 cells constitutively express Sox9 mRNA at relatively low levels. To examine regulation of Sox9 gene expression, we investigated the effects of calciotropic hormones and cytokines. Among these, retinoic acid (RA) specifically enhanced Sox9 mRNA expression in TC6 cells. The basal levels of Sox9 expression and its enhancement by RA were observed similarly at both permissive (33 degrees C) and nonpermissive (39 degrees C) temperatures. Furthermore, RA treatment enhanced the transcriptional activity of a reporter construct containing the Sry/Sox consensus sequence in TC6 cells. Moreover, RA treatment also enhanced the transcriptional activity of another reporter construct containing the enhancer region of the type II procollagen gene in TC6 cells. These observations indicate that SOX9 enhances aggrecan promoter activity and that its expression is up-regulated by RA in TC6 cells.

Citing Articles

Mechanism of Intervertebral Disc Degeneration via the β-Catenin/CCL2 Pathway in Sox9 Conditional Knockout Mice.

Aboushaala K, Chee A, Ko F, Alkhudari J, Sumughan S, An H JOR Spine. 2025; 8(1):e70053.

PMID: 40012719 PMC: 11864852. DOI: 10.1002/jsp2.70053.


Mechanism of action and new developments in the study of curcumin in the treatment of osteoarthritis: a narrative review.

Yang Y, Li J, Zhang J, Zhang K, Zhang A, Li P Inflammopharmacology. 2025; .

PMID: 40009345 DOI: 10.1007/s10787-025-01665-6.


MLL4 regulates postnatal palate growth and midpalatal suture development.

Lee J, Jung H, Pasqua B, Park Y, Tang Q, Jeon S Front Cell Dev Biol. 2025; 13:1466948.

PMID: 39925741 PMC: 11803150. DOI: 10.3389/fcell.2025.1466948.


The Role of SUMO1 Modification of SOX9 in Cartilage Development Stimulated by Zinc Ions in Mice.

Xue N, Zhao J, Yin J, Liu L, Yang Z, Zhai S Organogenesis. 2025; 21(1):2460269.

PMID: 39905673 PMC: 11801356. DOI: 10.1080/15476278.2025.2460269.


MLL4 regulates postnatal palate growth and midpalatal suture development.

Lee J, Jung H, Pasqua B, Park Y, Tang Q, Jeon S bioRxiv. 2024; .

PMID: 39372750 PMC: 11451598. DOI: 10.1101/2024.07.16.603832.